Logix Smart™ COVID-19 Test is authorized for emergency use by the FDA, and CE marked to be sold in Europe Madison, WI USA. (April 16, 2020) Promega Corporation has been contracted by Utah-based Co-Diagnostics, Inc. to support Co-Diagnostics’ efforts to manufacture test kits of its new Logix Smart™ COVID-19 Test. Promega originally provided the custom master mix used... Read more
SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) announces the Illumina SARS-CoV-2 Data Toolkit, a new suite of data analysis tools and workflow functionality for researchers working with the virus using next-generation sequencing (NGS). The toolkit makes it easier for researchers to detect and identify the SARS-CoV-2 viral sequence in their samples and contribute their findings to... Read more
Germantown, Maryland, and Hilden, Germany, April 15 2020 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced launch of its novel therascreen® BRAF V600E RGQ PCR Kit (therascreen BRAF V600E Kit) following U.S. Food and Drug Administration (FDA) approval as a companion diagnostic to the BRAF inhibitor, BRAFTOVI® (encorafenib), which the FDA has... Read more
New Test Uses BD MAX™ System to Augment Supply from Existing Collaborations; Test Results in Under Three HoursApr 13, 2020 FRANKLIN LAKES, N.J., April 13, 2020 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA)... Read more
Shimadzu Corporation is announcing the release of its “2019 Novel Coronavirus Detection Kit”, with sales beginning on 20th April. For the time being the kits will only be available in Japan, but preparations are underway to export these kits overseas from May onwards. Current PCR methods for the detection of the novel coronavirus (SARS-CoV-2) require... Read more
Bruker is proud to partner with Australian National Phenome Centre (ANPC) at Murdoch University to support the work of their researchers into the COVID-19 pandemic threat. The ANPC team, led by world-renowned phenomics pioneer and academician Professor Jeremy Nicholson, and working with the South Metropolitan Health Service COVID-19 Response Team and the broader Western Australian... Read more
Caption: Global COVID-19 Clinical Trial Tracker Waltham, MA — April 08, 2020 — Cytel Inc. has launched an open-access global COVID-19 Clinical Trial Tracker to help facilitate greater collaboration between researchers, policymakers, clinicians, journalists, philanthropists, and other critical stakeholders who need to understand the complex dynamics of the global response to finding a solution to the COVID-19 outbreak. This will enable... Read more
Date: 04/07/2020 HERCULES, Calif. – Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that the company is launching a blood-based immunoassay kit to identify antibodies to the coronavirus SARS-CoV-2, the virus associated with COVID-19. Preliminary performance of the assay has been established and the... Read more
New Test Immediately Available to Increase Capacity of Rapid, On-Site Testing of COVID-19 at Hospitals Across the U.S.Apr 3, 2020 FRANKLIN LAKES, N.J. and BIRMINGHAM, Ala. April 3, 2020 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and BioGX Inc., a molecular diagnostics company, today announced that the U.S.... Read more
Promega amplification reagent added to EUA list for laboratories that follow CDC’s testing protocols Madison, WI USA. (April 1, 2020) Promega Corporation’s GoTaq® Probe 1-Step RT-qPCR System is now in a Centers for Disease Control and Prevention COVID-19 diagnostic protocol for emergency use. The Promega tool is an approved master mix option for the CDC’s 2019-Novel Coronavirus... Read more